These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39267958)

  • 21. The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore.
    Mashaki Ceyhan E; Gürsöz H; Alkan A; Coşkun H; Koyuncu O; Walker S
    Front Pharmacol; 2018; 9():9. PubMed ID: 29422861
    [No Abstract]   [Full Text] [Related]  

  • 22. Industrial perceptions of medicines regulatory harmonization in the East African Community.
    Dansie LS; Odoch WD; Årdal C
    PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
    McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
    Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases.
    Affara M; Lagu HI; Achol E; Karamagi R; Omari N; Ochido G; Kezakarayagwa E; Kabatesi F; Nkeshimana A; Roba A; Ndia MN; Abudo MU; Kabanda A; Mpabuka E; Mwikarago EI; Kutjok PE; Samson DD; Deng LL; Moremi N; Kelly ME; Mkama PBM; Magesa A; Balinandi SK; Pimundu G; Nabadda SN; Puradiredja DI; Hinzmann J; Duraffour S; Gabriel M; Ruge G; Loag W; Ayiko R; Sonoiya SS; May J; Katende MJ; Gehre F
    BMC Med; 2021 Jul; 19(1):160. PubMed ID: 34238298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices.
    Sithole T; Salek S; Mahlangu G; Walker S
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):109-119. PubMed ID: 34645359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
    Sithole T; Mahlangu G; Walker S; Salek S
    Front Med (Lausanne); 2022; 9():898743. PubMed ID: 35547217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa.
    Keyter A; Salek S; McAuslane N; Banoo S; Azatyan S; Walker S
    Ther Innov Regul Sci; 2020 Sep; 54(5):1199-1207. PubMed ID: 32865802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
    Koyuncu O; Gursoz H; Alkan A; Cetintas HC; Pasaoglu T; Mashaki Ceyhan E; Walker S
    Front Pharmacol; 2019; 10():1557. PubMed ID: 32116658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
    Sithole T; Mahlangu G; Salek S; Walker S
    Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities.
    Danks L; Semete-Makokotlela B; Otwombe K; Parag Y; Walker S; Salek S
    Front Med (Lausanne); 2023; 10():1265058. PubMed ID: 37937144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency.
    Keyter A; Salek S; Banoo S; Walker S
    Int J Health Policy Manag; 2022 Jun; 11(6):795-809. PubMed ID: 33300773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries.
    Owusu-Asante M; Darko DM; Walker S; Salek S
    Front Pharmacol; 2022; 13():1069345. PubMed ID: 36506579
    [No Abstract]   [Full Text] [Related]  

  • 36. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.
    Narsai K; Masekela FB; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Health Serv Res; 2024 Jan; 24(1):111. PubMed ID: 38245720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.
    Shabani JBB; Kayitare E; Nyirimigabo E; Habyalimana V; Murindahabi MM; Ntirenganya L; Irasabwa C; Rutungwa E; Munyangaju JE; Hahirwa I
    J Pharm Policy Pract; 2022 Nov; 15(1):90. PubMed ID: 36434730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The South African Regulatory System: Past, Present, and Future.
    Keyter A; Banoo S; Salek S; Walker S
    Front Pharmacol; 2018; 9():1407. PubMed ID: 30618735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APEC Workshop Report of Good Review Practices on Medical Products.
    Lin HY; Chen SJ; Gau CS; Liu LL
    Ther Innov Regul Sci; 2015 Jul; 49(4):483-492. PubMed ID: 30222428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation.
    Lomeli-Silva A; Contreras-Salinas H; Barajas-Virgen MY; Romero-Lopez MS; Rodríguez-Herrera LY
    Ther Adv Drug Saf; 2024; 15():20420986241228119. PubMed ID: 38323190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.